BAJAJHCARE
OVERVALUEDBajaj Healthcare Limited
Healthcare · NSE
↓ 42.5% vs fair value
52W Low
₹273
+17.1% from low
52W High
₹643
-50.2% from high
Valuation Gauge
Current Price
₹320
Fair Value
₹225
Fair Value Analysis
₹225
Based on free cash flow projections and balance sheet strength analysis and earnings growth potential for Healthcare sector companies | Sector-cheap: P/E at 22th percentile vs sector peers. | CAUTION: ROCE declining (latest 12.1%) — returns on capital are falling; verify this isn't a value trap. | Growth capped at 11.8% (ROE 10.3%×1.15) — historical CAGR exceeds sustainable rate or COVID period unverifiable.
Cash Flow Analysis
40% weight
Balance Sheet Value
20% weight
Growth Valuation
40% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Solid Fundamentals
Profitability
ROE of 10.3% is acceptable for Healthcare sector (benchmark: 15%)
Debt & Leverage
D/E ratio of 0.5x is well within the Healthcare sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 19.6x trades at a 88% discount to Healthcare sector median (160x) — attractively valued
Cash Flow
FCF margin of 1.9% — very thin despite positive FCF (₹10 Cr)
Earnings Growth
5yr EPS CAGR of -17.9% — earnings are declining (sector avg growth: 18.7%)
Dividend
Dividend yield of 0.3% is symbolic — low but positive
Sentiment Trend — Last 30 Days
Historical Returns
Key Financials
EPS (TTM)
₹15.8
P/E Ratio
19.6x
P/B Ratio
2x
ROE
10.3%
ROCE
13.3%
Debt / Equity
0.49x
Beta
0.24
Div Yield
0.3%
FCF (Cr)
₹10 Cr
Revenue (Cr)
₹543 Cr
EPS Growth 5Y
-17.9%
Mkt Cap (Cr)
₹1,047 Cr
52W High
₹642.8
52W Low
₹273.3
Book Value/Share
₹151
Financial History
Annual P&L data not available yet.
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Community Pulse
Company Documents
Annual reports, concall transcripts & regulatory filings
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant